Female Pattern Hair Loss Clinical Trial
Official title:
Efficacy of Therapy With the Anti-androgen Spironolactone Compared to Topical Minoxidil in Female Pattern Hair Loss
Verified date | March 2017 |
Source | University of British Columbia |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study evaluates the efficacy of therapy with the anti-androgen spironolactone compared to topical minoxidil in female pattern hair loss.
Status | Completed |
Enrollment | 40 |
Est. completion date | March 9, 2009 |
Est. primary completion date | March 9, 2009 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 75 Years |
Eligibility |
Inclusion Criteria: - Subjects must be premenopausal women older than 18 with female pattern hair loss. Exclusion Criteria: - Androgen excess - Other scalp or hair disorders - Contraindications to spironolactone treatment, especially pregnancy, electrolyte imbalances, history of breast cancer, or intake of interfering drugs - Contraindications to minoxidil treatment, especially patients who are allergic to this treatment or have a history of low blood pressure or irregular heart beats |
Country | Name | City | State |
---|---|---|---|
Canada | UBC Division of Dermatology, Hair Research and Treatment Centre | Vancouver | British Columbia |
Lead Sponsor | Collaborator |
---|---|
University of British Columbia |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | hair density | after 3, 6 and 9 months | ||
Secondary | percentage of subjects who experience side effects | Unspecified | ||
Secondary | subject assessment of treatment effect | Unspecified |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06440655 -
The Efficacy and Safety of Platelet-rich Fibrin and Platelet Rich Plasma in Female Pattern Hair Loss Patients
|
N/A | |
Completed |
NCT04090801 -
Comparison of Topical Minoxidil 5% in Ethanol Plus Propylene Glycol Versus Minoxidil 5% in Ethanol Alone in Treatment of Women With Female Pattern Hair Loss
|
Phase 4 | |
Withdrawn |
NCT02486848 -
Minoxidil Dose Response Study in Females Identified Through IVD Testing as Non-Responders to 5% Topical Minoxidil
|
N/A | |
Completed |
NCT00958750 -
Efficacy and Safety Study to Compare Two Minoxidil Formulations on Women With Androgenetic Alopecia
|
Phase 3 | |
Completed |
NCT02206802 -
Minoxidil Response Testing in Females With Female Pattern Hair Loss
|
||
Completed |
NCT01900041 -
A Study to Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs 2% Minoxidil in Women With Female Pattern Hair Loss
|
Phase 2 |